Component,HTAN Participant ID,Age at Diagnosis,Year of Diagnosis,Primary Diagnosis,Site of Resection or Biopsy,Tissue or Organ of Origin,Morphology,Tumor Grade,Progression or Recurrence,Last Known Disease Status,Days to Last Follow up,Days to Last Known Disease Status,Method of Diagnosis,Prior Malignancy,Prior Treatment,Metastasis at Diagnosis,Metastasis at Diagnosis Site,First Symptom Prior to Diagnosis,Days to Diagnosis,Percent Tumor Invasion,Residual Disease,Synchronous Malignancy,Tumor Confined to Organ of Origin,Tumor Focality,Tumor Largest Dimension Diameter,Gross Tumor Weight,Breslow Thickness,Vascular Invasion Present,Vascular Invasion Type,Anaplasia Present,Anaplasia Present Type,Laterality,Perineural Invasion Present,Lymphatic Invasion Present,Lymph Nodes Positive,Lymph Nodes Tested,Peritoneal Fluid Cytological Status,Classification of Tumor,Best Overall Response,Mitotic Count,AJCC Clinical M,AJCC Clinical N,AJCC Clinical Stage,AJCC Clinical T,AJCC Pathologic M,AJCC Pathologic N,AJCC Pathologic Stage,AJCC Pathologic T,AJCC Staging System Edition,Cog Neuroblastoma Risk Group,Cog Rhabdomyosarcoma Risk Group,Gleason Grade Group,Gleason Grade Tertiary,Gleason Patterns Percent,Greatest Tumor Dimension,IGCCCG Stage,INPC Grade,INPC Histologic Group,INRG Stage,INSS Stage,International Prognostic Index,IRS Group,IRS Stage,ISS Stage,Lymph Node Involved Site,Margin Distance,Margins Involved Site,Medulloblastoma Molecular Classification,Micropapillary Features,Mitosis Karyorrhexis Index,Non Nodal Regional Disease,Non Nodal Tumor Deposits,Ovarian Specimen Status,Ovarian Surface Involvement,Pregnant at Diagnosis,Primary Gleason Grade,Secondary Gleason Grade,Supratentorial Localization,Tumor Depth,Tumor Grade,WHO CNS Grade,WHO NTE Grade,entityId,Id,Age Is Obfuscated,Days to Progression,Days to Progression Free,Days to Recurrence,Filename,Progression or Recurrence Anatomic Site,Progression or Recurrence Type
Diagnosis,HTA9_1,23266.0,2010.0,Infiltrating duct carcinoma NOS,Breast NOS,Breast NOS,8500/3,G3,Yes - Progression or Recurrence,Distant met recurrence/progression,4314.0,4314.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,G3,,,syn24983415,595465c3-e238-411b-afd2-3f3ca57d9818,,,,25726.0,,,
Diagnosis,HTA9_14,19707.0,2014.0,Infiltrating duct carcinoma NOS,Breast NOS,Breast NOS,8500/3,Unknown,Yes - Progression or Recurrence,Distant met recurrence/progression,2788.0,2788.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Unknown,,,syn29422212,07d1bb6f-8c35-4986-95d4-3d54a743e95f,,,,21352.0,,,
Diagnosis,HTA9_15,16977.0,2008.0,Infiltrating duct carcinoma NOS,Breast NOS,Breast NOS,8500/3,Unknown,Yes - Progression or Recurrence,Distant met recurrence/progression,5123.0,5123.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Unknown,,,syn29422214,bbfbeb5b-bf29-4a3f-abee-6f5cbf9317b0,,,,20267.0,,,
Diagnosis,HTA9_2,,,Infiltrating duct carcinoma NOS,Breast NOS,Unknown,Unknown,Unknown,Yes - Progression or Recurrence,Distant met recurrence/progression,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Unknown,,,syn29422216,21a01396-5167-4bf4-8ebf-50376cfe860f,,,,,,,
Diagnosis,HTA9_3,20006.0,2016.0,Infiltrating duct carcinoma NOS,Breast NOS,Lower-outer quadrant of breast,8500/3,Unknown,Yes - Progression or Recurrence,Distant met recurrence/progression,1560.0,1560.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Unknown,,,syn29422217,0cdbb853-f932-4448-99bb-f3ef120ccd85,,,,,,,
